| 摘要 |
Alzheimer's disease and immune deficiency disorders may be effectively treated by administering a DELTA 5-Androstene-3 beta -ol-17-one having a C7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis by administering a therapeutic amount of a DELTA 5-Androstene-3 beta -ol-17-one having a C7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis.
|
